Modulation of the Ribonucleotide Reductase-Antimetabolite Drug Interaction in Cancer Cell Lines

RRM1 is a determinant of gemcitabine efficacy in cancer patients. However, the precision of predicting tumor response based on RRM1 levels is not optimal. We used gene-specific overexpression and RNA interference to assess RRM1's impact on different classes of cytotoxic agents, on drug-drug int...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Jun, Oliveira, Paula, Li, Xueli, Chen, Zhengming, Bepler, Gerold
Formato: Texto
Lenguaje:English
Publicado: SAGE-Hindawi Access to Research 2010
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2952906/
https://www.ncbi.nlm.nih.gov/pubmed/20976259
http://dx.doi.org/10.4061/2010/597098

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2952906/
https://www.ncbi.nlm.nih.gov/pubmed/20976259
http://dx.doi.org/10.4061/2010/597098

Ejemplares similares